Status:
UNKNOWN
GOODBYE HARTMANN TRIAL: 100 YEARS OF HARTMANN'S PROCEDURE
Lead Sponsor:
Parma University Hospital
Collaborating Sponsors:
Fausto Catena
Gennaro Perrone
Conditions:
Emergencies
Colon Disease
Eligibility:
All Genders
18+ years
Brief Summary
Hartmann's procedure was described for the first time in 1921 as an alternative to abdominoperineal resection for the treatment of upper rectal tumours. Although Hartmann's procedure fell out of favo...
Detailed Description
Left-sided surgical acute colonic diseases (perforated diverticulitis with generalized peritonitis, colon perforation, large bowel obstruction, colon cancer perforation or obstruction, ischemic coliti...
Eligibility Criteria
Inclusion
- Aged 18 years or older;
- Patients admitted in Emergency setting for left-sided colonic disease (perforated diverticulitis with purulent or fecal peritonitis; large bowel perforation-obstruction; colon cancer perforation-obstruction; ischemic colitis; abdominal trauma).
- Patients who underwent urgent or emergency surgery for left-sided colonic disease (perforated diverticulitis with purulent or fecal peritonitis; large bowel perforationobstruction; colon cancer perforation-obstruction; ischemic colitis; abdominal trauma).
Exclusion
- Aged 17 or younger.
- Elective surgery.
- Non-surgical treatment.
- Patients with personal history of colorectal cancer treated surgically.
- Patients with stoma.
- Unstable patients who benefited of damage control procedures.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04829032
Start Date
March 1 2021
End Date
May 31 2022
Last Update
April 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mario Giuffrida
Parma, Italia, Italy, 43125